Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent ...Middle East

PR Newswire - News
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
MELBOURNE, Australia, Aug. 28, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-CDx, (Pixclara®[1], 18F-floretyrosine or...

Hence then, the article about telix submits nda for tlx101 cdx pixclara brain cancer imaging agent was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent )

Apple Storegoogle play

Last updated :

Also on site :



Latest News